Health Cor Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Health Cor Management, L.P.
- $106 Million
- Q4 2022
A detailed history of Health Cor Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Health Cor Management, L.P. holds 10,000 shares of BBIO stock, worth $349,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$349,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$882 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$877 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$526 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$434 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$216 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.17B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...